Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

2.

Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.

Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS.

World J Gastroenterol. 2014 Sep 28;20(36):13088-104. doi: 10.3748/wjg.v20.i36.13088.

3.

Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Elpek GÖ.

World J Gastroenterol. 2014 Jun 21;20(23):7260-76. doi: 10.3748/wjg.v20.i23.7260. Review.

4.

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

Kahles F, Findeisen HM, Bruemmer D.

Mol Metab. 2014 Mar 22;3(4):384-93. doi: 10.1016/j.molmet.2014.03.004. eCollection 2014 Jul. Review.

5.

Patterns of gene expression associated with Pten deficiency in the developing inner ear.

Kim HJ, Ryu J, Woo HM, Cho SS, Sung MK, Kim SC, Park MH, Park T, Koo SK.

PLoS One. 2014 Jun 3;9(6):e97544. doi: 10.1371/journal.pone.0097544. eCollection 2014.

6.

Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.

Liguori M, Solinas G, Germano G, Mantovani A, Allavena P.

Cancers (Basel). 2011 Sep 28;3(4):3740-61. doi: 10.3390/cancers3043740.

7.

Commensal microbiota contributes to chronic endocarditis in TAX1BP1 deficient mice.

Nakano S, Ikebe E, Tsukamoto Y, Wang Y, Matsumoto T, Mitsui T, Yahiro T, Inoue K, Kawazato H, Yasuda A, Ito K, Yokoyama S, Takahashi N, Hori M, Shimada T, Moriyama M, Kubota T, Ono K, Fujibuchi W, Jeang KT, Iha H, Nishizono A.

PLoS One. 2013 Sep 27;8(9):e73205. doi: 10.1371/journal.pone.0073205. eCollection 2013.

8.

Plasma osteopontin concentrations in patients with cutaneous melanoma.

Filia A, Elliott F, Wind T, Field S, Davies J, Kukalizch K, Randerson-Moor J, Harland M, Bishop DT, Banks RE, Newton-Bishop JA.

Oncol Rep. 2013 Oct;30(4):1575-80. doi: 10.3892/or.2013.2666. Epub 2013 Aug 8.

9.

Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner.

Reed JR, Stone MD, Beadnell TC, Ryu Y, Griffin TJ, Schwertfeger KL.

PLoS One. 2012;7(9):e45877. doi: 10.1371/journal.pone.0045877. Epub 2012 Sep 24.

10.

NF-κB as potential target in the treatment of melanoma.

Madonna G, Ullman CD, Gentilcore G, Palmieri G, Ascierto PA.

J Transl Med. 2012 Mar 20;10:53. doi: 10.1186/1479-5876-10-53. Review.

11.

Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration.

Zhang X, You X, Wang Q, Zhang T, Du Y, Lv N, Zhang Z, Zhang S, Shan C, Ye L, Zhang X.

PLoS One. 2012;7(2):e31458. doi: 10.1371/journal.pone.0031458. Epub 2012 Feb 15.

12.

Intracellular osteopontin (iOPN) and immunity.

Inoue M, Shinohara ML.

Immunol Res. 2011 Apr;49(1-3):160-72. doi: 10.1007/s12026-010-8179-5. Review.

13.

Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2.

Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X, Zhang D.

World J Gastroenterol. 2010 Sep 28;16(36):4541-8.

14.

Cancer biomarker discovery: the entropic hallmark.

Berretta R, Moscato P.

PLoS One. 2010 Aug 18;5(8):e12262. doi: 10.1371/journal.pone.0012262.

15.

Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.

Goparaju CM, Pass HI, Blasberg JD, Hirsch N, Donington JS.

J Thorac Oncol. 2010 Oct;5(10):1516-23. doi: 10.1097/JTO.0b013e3181eba6bd.

16.

Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action.

Wang L, Duan H, Wang Y, Liu K, Jiang P, Qu Z, Yagasaki K, Zhang G.

Cytotechnology. 2010 Aug;62(4):357-66. doi: 10.1007/s10616-010-9283-z. Epub 2010 Jul 4.

17.

Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.

Grotterød I, Maelandsmo GM, Boye K.

BMC Cancer. 2010 May 28;10:241. doi: 10.1186/1471-2407-10-241.

18.

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS.

J Clin Oncol. 2010 Feb 20;28(6):936-41. doi: 10.1200/JCO.2009.25.5711. Epub 2010 Jan 19.

19.

Lymphangiogenesis and lymphatic metastasis in breast cancer.

Ran S, Volk L, Hall K, Flister MJ.

Pathophysiology. 2010 Sep;17(4):229-51. doi: 10.1016/j.pathophys.2009.11.003. Epub 2009 Dec 24.

20.

RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Mi Z, Guo H, Russell MB, Liu Y, Sullenger BA, Kuo PC.

Mol Ther. 2009 Jan;17(1):153-61. doi: 10.1038/mt.2008.235. Epub 2008 Nov 4.

Items per page

Supplemental Content

Write to the Help Desk